ArticleCureus2025
Improving ST-Elevation Myocardial Infarction (STEMI) Care Through the Bahrain Stent Save a Life (BaSSaL) Program: A Prospective Study.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimThis study aimed to characterize the clinical features and predictors of adverse cardiovascular events in patients with ST-elevation myocardial infarction (STEMI) in Bahrain.
methodsPatients who presented with STEMI between January 2022 and December 2022 and underwent primary percutaneous coronary intervention (PPCI) are included in this single-center prospective study. We monitored each patient for a year after their initial hospitalization.
resultsOf the 787 patients in our study, 487 (62%) were not Bahraini. The majority of participants, 720 (91.5%), were men. The mean age was 56.6±10.88 years. Stent thrombosis occurred in eight patients (1.0%). During their hospitalization, 33 patients (4.2%) died. Fifty-three patients (6.7%) died within a year, including 20 patients (2.5%) who died during the follow-up after being discharged from the hospital.
conclusionThe establishment of nationwide quality control registries of successive STEMI patients, similar to the one we have with the Bahrain Stent Save a Life (BaSSaL) project, aids in pinpointing particular barriers to the implementation of guidelines and defining actions to guarantee that most STEMI patients may have lifesaving PPCI. Improving patient access to PPCI will reduce total ischemic time and mortality and help meet target revascularization timelines.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.